RESOURCES,
RESEARCH,
& MEDIA
Dr. Michelle Talks about Psychedelics and their Utilization in Nociplastic Pain at Cannadelic in Miami
Dr. Michelle talks about phantom limb pain, or nociplastic pain, which lives in the central nervous system - and what’s happening in the brain that’s causing the pain, as well as how neuroplasticity can help someone “learn” their way out of pain (the “faulty fire alarm”).
KETAMINE
KETAMINE
KETAMINE VIDEOS
Cristina Hernandez talks with Dr. Michelle Weiner about ketamine-assisted psychotherapy, and the importance of the biopsychosocial approach, as it relates to both pain management and neuroplasticity.
Dr. Michelle’s lecture on neuroplasticity, the endocannabinoid system, and ketamine-assisted therapy at The Brain Summit - this presentation includes all slides from the lecture and is chock-full of information!
KETAMINE RESEARCH & ARTICLES
FEATURED:
Ketamine and Sex Drive: Can This Depression Treatment Help in the Bedroom?
Dr. Michelle is interviewed by Giddy about how, for some people, ketamine treatments can help with the symptoms of depression and improve libido.
From MMJ to Special K: How Federal Cannabis Patients Use Ketamine to Escape pain
Dr. Michelle Weiner discusses how, at high doses ketamine, produces anesthesia; at lower doses, it relieves pain and causes hallucinations - and how patients are utilizing it to alleviate pain.
Cognitive Behavior Therapy May Sustain Antidepressant Effects of IV Ketamine in Treatment-Resistant Depression
Psychotherapy and integration with ketamine will enhance the outcome.
The Effects of Therapy-Guided IM Ketamine Treatment on Chronic Pain & Depressive Symptoms for Individuals with Fibromyalgia or Other Chronic Pain Syndromes and Comorbid Depression
Assessment of Initial Depressive State and Pain Relief With Ketamine in Patients with Chronic Refractory Pain
Oral ketamine for 6 weeks showed an alleviation of depressive symptoms in chronic pain, and ketamine improved both depression and pain.
Time to Relapse After a Single Administration of Intravenous Ketamine Augmentation in Unipolar Treatment-resistant Depression
Of the 60 randomized participants who received a single ketamine (0.1, 0.5, or 1.0 mg/kg) infusion, 19 (34%) met criteria for remission and 27 (48%) for response, on day 3 post-infusion.
Cognitive Behavior Therapy May Sustain Antidepressant Effects of IV Ketamine in Treatment-Resistant Depression
CBT may sustain the antidepressant effects of ketamine in TRD. Well-powered randomized controlled trials are warranted to further investigate this treatment combination.
Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
This randomized controlled trial provides the first evidence of efficacy of repeated ketamine infusions in reducing symptom severity in individuals with chronic PTSD.
Ketamine’s antidepressive effects tied to opioid system in brain (Stanford Medicine)
Ketamine’s antidepressive effects require activation of opioid receptors in the brain, a new Stanford study shows. The surprising finding may alter how new antidepressants are developed and administered in order to mitigate the risk of opioid dependence.
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices
Aa view of KAP’scurrent status combining data from three different related centers, with attendant outcomes with correlations.
CURIOUS ABOUT KETAMINE ASSISTED THERAPY?
The COVID-19 cannabis health study: Results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States
Dr. Weiner and researchers studied how adult medicinal cannabis users with chronic health conditions changed their habits during the COVID-19 pandemic. They found that those managing mental health issues were most likely to use more cannabis, with some switching to edibles over smoking due to coronavirus concerns.
DOWNLOAD THE PDF HERE.
CANNABIS
CANNABIS
CANNABIS VIDEOS
Educational wellness video with Michelle Weiner, DO MPH and Michelle Kavall, RN MSN, about the Endocannabinoid system, CBD, Medical Cannabis and health care in South Florida
Holistic Medicine Series Session 1 with Dr. Michelle Weiner & Stacia Smith
Dr. Michelle Weiner talks live on iheart radio about Medical Cannabis in Florida.
A conversation with medical cannabis expert Michelle Weiner, DO, MPH, and Shari Kaplan, LCSW about the Endocannabinoid system and mental health.
All Health TV Patient Outcome, Medical Marijuana: Dr. Michelle Weiner talks about pain management & marijuana
Dr. Michelle Weiner is interviewed by NBC News about the Growing Pains for Medical Marijuana in Florida
Dr. Michelle Weiner explains the process of getting a Medical Marijuana Card in Florida.
Let’s Be Blunt with Montel & Dr. Michelle Weiner
NBC News interviewed Dr. Weiner on PTSD and the Medical Marijuana Loophole
Dr. Michelle Weiner explains what the Endocannabinoid system is and the difference between THC and CBD.
Mindful Medicines with Medical Cannabis and CBD expert, and educator, Dr. Michelle Weiner
Dr. Michelle Weiner discusses how patients have benefited from using CBD with little or no side effects.
CANNABIS RESEARCH & ARTICLES
Clinical Endocannabinoid Deficiency Syndrom (CED) - by Dr. Weiner in HighLife
The theory of Clinical Endocannabinoid Deficiency (CED) is based on the concept that many brain disorders are associated with neurotransmitter deficiencies.
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (British Journal of Pharmacology)
Explores the therapeutic potential of cannabis terpenoids - including limonene, myrcene, and caryophyllene - and their synergistic interactions with phytocannabinoids.
READ (PDF)
The Microbiome, Gut-Brain Axis, and Cannabis
This article proposes the theory of clinical endocannabinoid deficiency (CED) to explain common subjective pain conditions like migraine, fibromyalgia, and irritable bowel syndrome.
Eat Fat or Oil before Cannabis Use for a Faster Onset
High-fat meal significantly increased THC and 11-OH-THC blood levels and prolonged their effects compared to a fasted state, while 5 mg THC produced higher peak THC levels in females versus males when fasted but was otherwise safe and well-tolerated.
700 Medical Cannabis Studies, sorted by Disease
Here is a collection of clinical studies, papers and references providing the ultimate resource for medical disorders helped by cannabis.
A Retrospective Medical Record Review of Adults with Non-Cancer Diagnoses Prescribed Medicinal Cannabis
The findings of this study suggest that a balanced formulation of medicinal cannabis is safe and effective in treating older patients, with treatment-resistant neurological conditions seeing the most benefits.
CURIOUS ABOUT CANNABIS THERAPY?
NUTRITION & LIFESTYLE
NUTRITION & LIFESTYLE
Download these PDFs to support you on your holistic health journey
